Loading company…
Chicago-based SkinCure Oncology offers Image-Guided Superficial Radiotherapy, a non-surgical treatment for non-melanoma skin cancer.
Founded in 2016 and headquartered in Chicago, US, SkinCure Oncology LLC treats non-melanoma skin cancer with Image-Guided Superficial Radiotherapy (IG-SRT), a non-invasive alternative to Mohs surgery. Its clients are dermatology practices, more than 360 of them across the US, which fund infrastructure while SkinCure installs equipment and staffs treatment. On September 30, 2024, it raised USD 30.00 mn in a GROWTH round from Seacoast Capital, and H.I.G. Capital acquired the company in September 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in